Acute lower respiratory illness (LRI) is the leading cause of disease world
wide as measured by disability-adjusted life years. New strategies are nece
ssary to decrease the disease burden that is largely borne by infants. Resp
iratory syncytial virus is the most important cause of LRI in infants. Lowe
r respiratory illness can be prevented by endowing infants with high levels
of neutralizing antibodies from mothers whose antibodies are boosted durin
g pregnancy with a potent subunit vaccine. Another important cause of infan
t mortality is group B streptococcus sepsis in the neonatal period; materna
l immunization with a group B conjugate vaccine could prevent this devastat
ing infection.